Unknown

Dataset Information

0

Simultaneous FET-PET and contrast-enhanced MRI based on hybrid PET/MR improves delineation of tumor spatial biodistribution in gliomas: a biopsy validation study.


ABSTRACT: PURPOSE:Glioma treatment planning requires precise tumor delineation, which is typically performed with contrast-enhanced (CE) MRI. However, CE MRI fails to reflect the entire extent of glioma. O-(2-18F-fluoroethyl)-L-tyrosine (18F-FET) PET may detect tumor volumes missed by CE MRI. We investigated the clinical value of simultaneous FET-PET and CE MRI in delineating tumor extent before treatment planning. Guided stereotactic biopsy was used to validate the findings. METHODS:Conventional MRI and 18F-FET PET were performed simultaneously on a hybrid PET/MR in 33 patients with histopathologically confirmed glioma. Tumor volumes were quantified using a tumor-to-brain ratio???1.6 (VPET) and a visual threshold (VCE). We visually assessed abnormal areas on FLAIR images and calculated Dice's coefficient (DSC), overlap volume (OV), discrepancy-PET, and discrepancy-CE. Additionally, several stereotactic biopsy samples were taken from "matched" or "mismatched" FET-PET and CE MRI regions. RESULTS:Among 31 patients (93.94%), FET-PET delineated significantly larger tumor volumes than CE MRI (77.84?±?51.74 cm3 vs. 34.59?±?27.07 cm3, P?

SUBMITTER: Song S 

PROVIDER: S-EPMC7188715 | biostudies-literature | 2020 Jun

REPOSITORIES: biostudies-literature

altmetric image

Publications

Simultaneous FET-PET and contrast-enhanced MRI based on hybrid PET/MR improves delineation of tumor spatial biodistribution in gliomas: a biopsy validation study.

Song Shuangshuang S   Cheng Ye Y   Ma Jie J   Wang Leiming L   Dong Chengyan C   Wei Yukui Y   Xu Geng G   An Yang Y   Qi Zhigang Z   Lin Qingtang Q   Lu Jie J  

European journal of nuclear medicine and molecular imaging 20200109 6


<h4>Purpose</h4>Glioma treatment planning requires precise tumor delineation, which is typically performed with contrast-enhanced (CE) MRI. However, CE MRI fails to reflect the entire extent of glioma. O-(2-<sup>18</sup>F-fluoroethyl)-L-tyrosine (<sup>18</sup>F-FET) PET may detect tumor volumes missed by CE MRI. We investigated the clinical value of simultaneous FET-PET and CE MRI in delineating tumor extent before treatment planning. Guided stereotactic biopsy was used to validate the findings.  ...[more]

Similar Datasets

| S-EPMC6129224 | biostudies-literature
| S-EPMC6127131 | biostudies-literature
| S-EPMC7661078 | biostudies-literature
| S-EPMC5932747 | biostudies-literature
| S-EPMC3495949 | biostudies-literature
| S-EPMC6374762 | biostudies-literature
| S-EPMC6474595 | biostudies-literature
| S-EPMC7985095 | biostudies-literature
| S-EPMC6118093 | biostudies-literature